 | • レポートコード：D0GIR-02634 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、マイコプラズマ診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。マイコプラズマ診断の種類別市場規模（キット、試薬、機器、ソフトウェア、サービス）、用途別市場規模（病院、診断研究所、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Agilent Technologies, Inc、Savyon Diagnostics、Charles River Laboratories International, Inc、Thermo Fisher Scientific Inc、Takara Bio Inc (Takara Holding Company Inc.)、PromoCell GmbH、Sartorius Stedim BioOutsource Limited、Lonza Group、Merck KGaA、Tecan Trading AG (Tecan Group)、American Type Culture Collection (ATCC)、F Hoffmann-La Roche ・地域別グローバル市場分析 2015年-2020年 ・マイコプラズマ診断の北米市場（アメリカ、カナダ、メキシコ） ・マイコプラズマ診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・マイコプラズマ診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・マイコプラズマ診断の南米市場（ブラジル、アルゼンチン） ・マイコプラズマ診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：キット、試薬、機器、ソフトウェア、サービス ・用途別分析：病院、診断研究所、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Mycoplasma Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.8% in the forecast period of 2020 to 2025 and will expected to reach USD 850.1 million by 2025, from USD 679.7 million in 2019.
The Mycoplasma Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Mycoplasma Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Mycoplasma Diagnostics market has been segmented into:
Kits & Reagents
Instruments
Software & Services
By Application, Mycoplasma Diagnostics has been segmented into:
Hospitals
Diagnostic Laboratories
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Mycoplasma Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Mycoplasma Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Mycoplasma Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the Mycoplasma Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Mycoplasma Diagnostics Market Share Analysis
Mycoplasma Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Mycoplasma Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Mycoplasma Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in Mycoplasma Diagnostics are:
Agilent Technologies, Inc
Savyon Diagnostics
Charles River Laboratories International, Inc
Thermo Fisher Scientific Inc
Takara Bio Inc (Takara Holding Company Inc.)
PromoCell GmbH
Sartorius Stedim BioOutsource Limited
Lonza Group
Merck KGaA
Tecan Trading AG (Tecan Group)
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Table of Contents
1 Mycoplasma Diagnostics Market Overview
1.1 Product Overview and Scope of Mycoplasma Diagnostics
1.2 Classification of Mycoplasma Diagnostics by Type
1.2.1 Global Mycoplasma Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Mycoplasma Diagnostics Revenue Market Share by Type in 2019
1.2.3 Kits & Reagents
1.2.4 Instruments
1.2.5 Software & Services
1.3 Global Mycoplasma Diagnostics Market by Application
1.3.1 Overview: Global Mycoplasma Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Clinics
1.3.5 Others
1.4 Global Mycoplasma Diagnostics Market by Regions
1.4.1 Global Mycoplasma Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Mycoplasma Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Mycoplasma Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Mycoplasma Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mycoplasma Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Mycoplasma Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mycoplasma Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Agilent Technologies, Inc
2.1.1 Agilent Technologies, Inc Details
2.1.2 Agilent Technologies, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Agilent Technologies, Inc SWOT Analysis
2.1.4 Agilent Technologies, Inc Product and Services
2.1.5 Agilent Technologies, Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Savyon Diagnostics
2.2.1 Savyon Diagnostics Details
2.2.2 Savyon Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Savyon Diagnostics SWOT Analysis
2.2.4 Savyon Diagnostics Product and Services
2.2.5 Savyon Diagnostics Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Charles River Laboratories International, Inc
2.3.1 Charles River Laboratories International, Inc Details
2.3.2 Charles River Laboratories International, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Charles River Laboratories International, Inc SWOT Analysis
2.3.4 Charles River Laboratories International, Inc Product and Services
2.3.5 Charles River Laboratories International, Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific Inc
2.4.1 Thermo Fisher Scientific Inc Details
2.4.2 Thermo Fisher Scientific Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific Inc SWOT Analysis
2.4.4 Thermo Fisher Scientific Inc Product and Services
2.4.5 Thermo Fisher Scientific Inc Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takara Bio Inc (Takara Holding Company Inc.)
2.5.1 Takara Bio Inc (Takara Holding Company Inc.) Details
2.5.2 Takara Bio Inc (Takara Holding Company Inc.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takara Bio Inc (Takara Holding Company Inc.) SWOT Analysis
2.5.4 Takara Bio Inc (Takara Holding Company Inc.) Product and Services
2.5.5 Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 PromoCell GmbH
2.6.1 PromoCell GmbH Details
2.6.2 PromoCell GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PromoCell GmbH SWOT Analysis
2.6.4 PromoCell GmbH Product and Services
2.6.5 PromoCell GmbH Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sartorius Stedim BioOutsource Limited
2.7.1 Sartorius Stedim BioOutsource Limited Details
2.7.2 Sartorius Stedim BioOutsource Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sartorius Stedim BioOutsource Limited SWOT Analysis
2.7.4 Sartorius Stedim BioOutsource Limited Product and Services
2.7.5 Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza Group
2.8.1 Lonza Group Details
2.8.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza Group SWOT Analysis
2.8.4 Lonza Group Product and Services
2.8.5 Lonza Group Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck KGaA SWOT Analysis
2.9.4 Merck KGaA Product and Services
2.9.5 Merck KGaA Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Tecan Trading AG (Tecan Group)
2.10.1 Tecan Trading AG (Tecan Group) Details
2.10.2 Tecan Trading AG (Tecan Group) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Tecan Trading AG (Tecan Group) SWOT Analysis
2.10.4 Tecan Trading AG (Tecan Group) Product and Services
2.10.5 Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 American Type Culture Collection (ATCC)
2.11.1 American Type Culture Collection (ATCC) Details
2.11.2 American Type Culture Collection (ATCC) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 American Type Culture Collection (ATCC) SWOT Analysis
2.11.4 American Type Culture Collection (ATCC) Product and Services
2.11.5 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 F Hoffmann-La Roche
2.12.1 F Hoffmann-La Roche Details
2.12.2 F Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 F Hoffmann-La Roche SWOT Analysis
2.12.4 F Hoffmann-La Roche Product and Services
2.12.5 F Hoffmann-La Roche Mycoplasma Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Mycoplasma Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Mycoplasma Diagnostics Players Market Share
3.2.2 Top 10 Mycoplasma Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Mycoplasma Diagnostics Revenue and Market Share by Regions
4.2 North America Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Mycoplasma Diagnostics Revenue by Countries
5.1 North America Mycoplasma Diagnostics Revenue by Countries (2015-2020)
5.2 USA Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Mycoplasma Diagnostics Revenue by Countries
6.1 Europe Mycoplasma Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Mycoplasma Diagnostics Revenue by Countries
7.1 Asia-Pacific Mycoplasma Diagnostics Revenue by Countries (2015-2020)
7.2 China Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Mycoplasma Diagnostics Revenue by Countries
8.1 South America Mycoplasma Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Mycoplasma Diagnostics by Countries
9.1 Middle East & Africa Mycoplasma Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Mycoplasma Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Mycoplasma Diagnostics Market Forecast by Type (2019-2024)
10.3 Kits & Reagents Revenue Growth Rate (2015-2025)
10.4 Instruments Revenue Growth Rate (2015-2025)
10.5 Software & Services Revenue Growth Rate (2015-2025)
11 Global Mycoplasma Diagnostics Market Segment by Application
11.1 Global Mycoplasma Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Mycoplasma Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Clinics Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Mycoplasma Diagnostics Market Size Forecast (2021-2025)
12.1 Global Mycoplasma Diagnostics Market Size Forecast (2021-2025)
12.2 Global Mycoplasma Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Mycoplasma Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Mycoplasma Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Mycoplasma Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Mycoplasma Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Agilent Technologies, Inc Corporate Information, Location and Competitors
Table 6. Agilent Technologies, Inc Mycoplasma Diagnostics Major Business
Table 7. Agilent Technologies, Inc Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Agilent Technologies, Inc SWOT Analysis
Table 9. Agilent Technologies, Inc Mycoplasma Diagnostics Product and Solutions
Table 10. Agilent Technologies, Inc Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Savyon Diagnostics Corporate Information, Location and Competitors
Table 12. Savyon Diagnostics Mycoplasma Diagnostics Major Business
Table 13. Savyon Diagnostics Mycoplasma Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Savyon Diagnostics SWOT Analysis
Table 15. Savyon Diagnostics Mycoplasma Diagnostics Product and Solutions
Table 16. Savyon Diagnostics Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Charles River Laboratories International, Inc Corporate Information, Location and Competitors
Table 18. Charles River Laboratories International, Inc Mycoplasma Diagnostics Major Business
Table 19. Charles River Laboratories International, Inc Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Charles River Laboratories International, Inc SWOT Analysis
Table 21. Charles River Laboratories International, Inc Mycoplasma Diagnostics Product and Solutions
Table 22. Charles River Laboratories International, Inc Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Inc Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Inc Mycoplasma Diagnostics Major Business
Table 25. Thermo Fisher Scientific Inc Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific Inc SWOT Analysis
Table 27. Thermo Fisher Scientific Inc Mycoplasma Diagnostics Product and Solutions
Table 28. Thermo Fisher Scientific Inc Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takara Bio Inc (Takara Holding Company Inc.) Corporate Information, Location and Competitors
Table 30. Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Major Business
Table 31. Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Takara Bio Inc (Takara Holding Company Inc.) SWOT Analysis
Table 33. Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Product and Solutions
Table 34. Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. PromoCell GmbH Corporate Information, Location and Competitors
Table 36. PromoCell GmbH Mycoplasma Diagnostics Major Business
Table 37. PromoCell GmbH Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. PromoCell GmbH SWOT Analysis
Table 39. PromoCell GmbH Mycoplasma Diagnostics Product and Solutions
Table 40. PromoCell GmbH Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sartorius Stedim BioOutsource Limited Corporate Information, Location and Competitors
Table 42. Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Major Business
Table 43. Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Sartorius Stedim BioOutsource Limited SWOT Analysis
Table 45. Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Product and Solutions
Table 46. Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Group Corporate Information, Location and Competitors
Table 48. Lonza Group Mycoplasma Diagnostics Major Business
Table 49. Lonza Group Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Lonza Group SWOT Analysis
Table 51. Lonza Group Mycoplasma Diagnostics Product and Solutions
Table 52. Lonza Group Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck KGaA Corporate Information, Location and Competitors
Table 54. Merck KGaA Mycoplasma Diagnostics Major Business
Table 55. Merck KGaA Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Merck KGaA SWOT Analysis
Table 57. Merck KGaA Mycoplasma Diagnostics Product and Solutions
Table 58. Merck KGaA Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Tecan Trading AG (Tecan Group) Corporate Information, Location and Competitors
Table 60. Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Major Business
Table 61. Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Tecan Trading AG (Tecan Group) SWOT Analysis
Table 63. Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Product and Solutions
Table 64. Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. American Type Culture Collection (ATCC) Corporate Information, Location and Competitors
Table 66. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Major Business
Table 67. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. American Type Culture Collection (ATCC) SWOT Analysis
Table 69. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product and Solutions
Table 70. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. F Hoffmann-La Roche Corporate Information, Location and Competitors
Table 72. F Hoffmann-La Roche Mycoplasma Diagnostics Major Business
Table 73. F Hoffmann-La Roche Mycoplasma Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. F Hoffmann-La Roche SWOT Analysis
Table 75. F Hoffmann-La Roche Mycoplasma Diagnostics Product and Solutions
Table 76. F Hoffmann-La Roche Mycoplasma Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Mycoplasma Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 78. Global Mycoplasma Diagnostics Revenue Share by Players (2015-2020)
Table 79. Global Mycoplasma Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Mycoplasma Diagnostics Revenue Market Share by Regions (2015-2020)
Table 81. North America Mycoplasma Diagnostics Revenue by Countries (2015-2020)
Table 82. North America Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Table 83. Europe Mycoplasma Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Mycoplasma Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Mycoplasma Diagnostics Revenue by Countries (2015-2020)
Table 86. South America Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Mycoplasma Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Table 89. Global Mycoplasma Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 90. Global Mycoplasma Diagnostics Revenue Share by Type (2015-2020)
Table 91. Global Mycoplasma Diagnostics Revenue Forecast by Type (2021-2025)
Table 92. Global Mycoplasma Diagnostics Revenue by Application (2015-2020)
Table 93. Global Mycoplasma Diagnostics Revenue Share by Application (2015-2020)
Table 94. Global Mycoplasma Diagnostics Revenue Forecast by Application (2021-2025)
Table 95. Global Mycoplasma Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Mycoplasma Diagnostics Picture
Figure 2. Global Mycoplasma Diagnostics Revenue Market Share by Type in 2019
Figure 3. Kits & Reagents Picture
Figure 4. Instruments Picture
Figure 5. Software & Services Picture
Figure 6. Mycoplasma Diagnostics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Diagnostic Laboratories Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Mycoplasma Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Mycoplasma Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Mycoplasma Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Mycoplasma Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Mycoplasma Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Mycoplasma Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Mycoplasma Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Mycoplasma Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Mycoplasma Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Mycoplasma Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Mycoplasma Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Mycoplasma Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Mycoplasma Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Mycoplasma Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Mycoplasma Diagnostics Revenue Share by Type in 2019
Figure 61. Global Mycoplasma Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global Kits & Reagents Revenue Growth Rate (2015-2020)
Figure 63. Global Instruments Revenue Growth Rate (2015-2020)
Figure 64. Global Software & Services Revenue Growth Rate (2015-2020)
Figure 65. Global Mycoplasma Diagnostics Revenue Share by Application (2015-2020)
Figure 66. Global Mycoplasma Diagnostics Revenue Share by Application in 2019
Figure 67. Global Mycoplasma Diagnostics Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Mycoplasma Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Mycoplasma Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Mycoplasma Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Mycoplasma Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
尿路上皮がん診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Urothelial Carcinoma Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Urothelial C…- 獣医分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Veterinary Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.4% in the forecast period of 2020 to 2025 and will expected to reach USD 480.7 million by 2025, from USD 375.7 million in 2019. The Veter…
- 体外診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global In-vitro Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The In-vitro Diagnostics mar…
- 一般インフルエンザ診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The General Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 分子診断検査及び試薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Diagnostics Tests & Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…